A Multicenter Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2015
At a glance
- Drugs Levonorgestrel (Primary) ; Medroxyprogesterone (Primary)
- Indications Endometrial hyperplasia
- Focus Therapeutic Use
- 11 May 2012 Actual patient number is 170 according to ClinicalTrials.gov.
- 11 May 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 03 Mar 2010 New trial record